Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning

Ahmadzadehfar, Hojjat; Essler, Markus; Rahbar, Kambiz; Afshar Oromieh, Ali (2018). Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning. PET clinics, 13(4), pp. 491-503. Elsevier 10.1016/j.cpet.2018.05.005

Full text not available from this repository. (Request a copy)

The skeleton is a common site for cancer metastases. Bone metastases are a major cause of morbidity and mortality and associated with pain, pathologic fractures, spinal cord compression, and decreased survival. Various radionuclides have been used for pain therapy. Recently, an α-emitter has been shown to improve overall survival of patients with bone metastases from castration-resistant prostate cancer and was approved as a therapeutic agent. The aim of this article is to provide an overview regarding state of the art radionuclide therapy options for bone metastases, with focus on the role of PET imaging in therapy planning.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Afshar Oromieh, Ali

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1556-8598

Publisher:

Elsevier

Language:

English

Submitter:

Sabine Lanz

Date Deposited:

15 Apr 2019 15:07

Last Modified:

15 Apr 2019 15:07

Publisher DOI:

10.1016/j.cpet.2018.05.005

PubMed ID:

30219184

URI:

https://boris.unibe.ch/id/eprint/125640

Actions (login required)

Edit item Edit item
Provide Feedback